Healthcare
Live Price
Offline$282.08
+1.01% today
1Y Change
-10.73%
Window
Jun 25, 2025 โ Jun 22, 2026
Coverage: 248 bars ยท Jun 25, 2025 โ Jun 22, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
The Cigna Group (CI) is a Healthcare stock with a market cap of $72.68B and listed on NYSE. The stock last traded around $282.08 and down 10.7% across the available one-year price window (Jun 25, 2025 โ Jun 22, 2026). Baseline metrics include revenue growth of +11.3%, EPS growth of +82.0%, a dividend yield of 2.2%. What stands out right now is revenue +11.3%, EPS +82.0%, free cash flow -6.3% with operating margin 3.4% and ROIC 7.6%. The dividend is present but secondary, with a yield around 2.2%. Valuation is more restrained than many high-expectation growth names at P/E 11.5 and price/sales 0.3. Stock Foundry combines CI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+11.3% vs +7.6% peer median
Operating Margin
Below sector median
+3.4% vs +19.4% peer median
P/E
Below sector median
11.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 30, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +11.3% and EPS at +82.0%, with operating margin around 3.4%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 2.2%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.9% over the next 5 trading days and finished higher after 2 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 30, 2026 | โ | -2.6% | -2.3% | -4.5% |
2026 Feb 5, 2026 | +2.5% | +2.6% | +1.1% | -4.5% |
2025 Oct 30, 2025 | +2.5% | -1.1% | +3.8% | +12.2% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CI
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CI Max Drawdown
-26.91%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for CI and SPY.
Company Overview
The Cigna Group
NYSE
The Cigna Group is a global health services organization dedicated to providing a broad range of insurance products and related services. Its core offerings encompass medical, dental, behavioral health, pharmacy benefit management, vision care, and supplemental benefits. Through the Evernorth Health Services segment, it partners with health plans, employers, governmental organizations, and providers to address challenges in pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery management. The Cigna Healthcare segment delivers comprehensive medical and coordinated solutions via U.S. Healthcare and International Health operations. Other Operations include ongoing and exited businesses, while Corporate handles interest expenses, litigation, pension plans, and overhead. The Cigna Group connects clients with providers, pharmacies, and wellness partners across the United States and select international markets in Asia, Europe, the Middle East, and Latin America, emphasizing integrated solutions for clinical needs and cost efficiency. Founded in 1792 and headquartered in Bloomfield, Connecticut, it serves individuals, employers, and organizations with data-driven care management and digital health tools.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.